MCID: CRD163
MIFTS: 20

Cardiofaciocutaneous Syndrome 2

Categories: Genetic diseases, Cardiovascular diseases, Rare diseases, Neuronal diseases, Skin diseases, Fetal diseases

Aliases & Classifications for Cardiofaciocutaneous Syndrome 2

MalaCards integrated aliases for Cardiofaciocutaneous Syndrome 2:

Name: Cardiofaciocutaneous Syndrome 2 57 75 29 6 73
Cfc2 57 75
Cardiofaciocutaneous Syndrome, Type 2 40

Characteristics:

HPO:

32
cardiofaciocutaneous syndrome 2:
Inheritance autosomal dominant inheritance


Classifications:



Summaries for Cardiofaciocutaneous Syndrome 2

UniProtKB/Swiss-Prot : 75 Cardiofaciocutaneous syndrome 2: A form of cardiofaciocutaneous syndrome, a multiple congenital anomaly disorder characterized by a distinctive facial appearance, heart defects and mental retardation. Heart defects include pulmonic stenosis, atrial septal defects and hypertrophic cardiomyopathy. Some affected individuals present with ectodermal abnormalities such as sparse, friable hair, hyperkeratotic skin lesions and a generalized ichthyosis-like condition. Typical facial features are similar to Noonan syndrome. They include high forehead with bitemporal constriction, hypoplastic supraorbital ridges, downslanting palpebral fissures, a depressed nasal bridge, and posteriorly angulated ears with prominent helices. CFC2 patients often do not have the skin abnormalities, such as ichthyosis, hyperkeratosis, and hemangioma observed in CFC1.

MalaCards based summary : Cardiofaciocutaneous Syndrome 2, is also known as cfc2. An important gene associated with Cardiofaciocutaneous Syndrome 2 is KRAS (KRAS Proto-Oncogene, GTPase). Affiliated tissues include skin and heart, and related phenotypes are high palate and coarse facial features

OMIM : 57 Cardiofaciocutaneous (CFC) syndrome is a multiple congenital anomaly disorder characterized by a distinctive facial appearance, heart defects, and mental retardation (summary by Niihori et al., 2006). In a phenotypic comparison of BRAF (164757)-positive and KRAS-positive individuals with CFC, Niihori et al. (2006) observed that patients with KRAS mutations did not have the skin abnormalities, such as ichthyosis, hyperkeratosis, and hemangioma, that were present in patients with BRAF mutation. (615278)

Related Diseases for Cardiofaciocutaneous Syndrome 2

Symptoms & Phenotypes for Cardiofaciocutaneous Syndrome 2

Clinical features from OMIM:

615278

Human phenotypes related to Cardiofaciocutaneous Syndrome 2:

32 (show all 15)
# Description HPO Frequency HPO Source Accession
1 high palate 32 HP:0000218
2 coarse facial features 32 HP:0000280
3 broad forehead 32 HP:0000337
4 posteriorly rotated ears 32 HP:0000358
5 low-set ears 32 HP:0000369
6 anteverted nares 32 HP:0000463
7 ptosis 32 HP:0000508
8 myopia 32 HP:0000545
9 global developmental delay 32 HP:0001263
10 mitral valve prolapse 32 HP:0001634
11 curly hair 32 HP:0002212
12 fine hair 32 HP:0002213
13 absent eyebrow 32 HP:0002223
14 peripheral axonal neuropathy 32 HP:0003477
15 sparse hair 32 HP:0008070

Drugs & Therapeutics for Cardiofaciocutaneous Syndrome 2

Search Clinical Trials , NIH Clinical Center for Cardiofaciocutaneous Syndrome 2

Genetic Tests for Cardiofaciocutaneous Syndrome 2

Genetic tests related to Cardiofaciocutaneous Syndrome 2:

# Genetic test Affiliating Genes
1 Cardiofaciocutaneous Syndrome 2 29 KRAS

Anatomical Context for Cardiofaciocutaneous Syndrome 2

MalaCards organs/tissues related to Cardiofaciocutaneous Syndrome 2:

41
Skin, Heart

Publications for Cardiofaciocutaneous Syndrome 2

Variations for Cardiofaciocutaneous Syndrome 2

UniProtKB/Swiss-Prot genetic disease variations for Cardiofaciocutaneous Syndrome 2:

75
# Symbol AA change Variation ID SNP ID
1 KRAS p.Pro34Arg VAR_026110 rs104894366
2 KRAS p.Gly60Arg VAR_026112 rs104894359
3 KRAS p.Gln22Glu VAR_064850
4 KRAS p.Tyr71His VAR_069784 rs387907205
5 KRAS p.Lys147Glu VAR_069785 rs387907206

ClinVar genetic disease variations for Cardiofaciocutaneous Syndrome 2:

6
(show all 16)
# Gene Variation Type Significance SNP ID Assembly Location
1 KRAS NM_004985.4(KRAS): c.178G> C (p.Gly60Arg) single nucleotide variant Pathogenic rs104894359 GRCh37 Chromosome 12, 25380280: 25380280
2 KRAS NM_004985.4(KRAS): c.178G> C (p.Gly60Arg) single nucleotide variant Pathogenic rs104894359 GRCh38 Chromosome 12, 25227346: 25227346
3 KRAS NM_004985.4(KRAS): c.458A> T (p.Asp153Val) single nucleotide variant Pathogenic rs104894360 GRCh37 Chromosome 12, 25362838: 25362838
4 KRAS NM_004985.4(KRAS): c.458A> T (p.Asp153Val) single nucleotide variant Pathogenic rs104894360 GRCh38 Chromosome 12, 25209904: 25209904
5 KRAS NM_004985.4(KRAS): c.101C> G (p.Pro34Arg) single nucleotide variant Pathogenic/Likely pathogenic rs104894366 GRCh37 Chromosome 12, 25398218: 25398218
6 KRAS NM_004985.4(KRAS): c.101C> G (p.Pro34Arg) single nucleotide variant Pathogenic/Likely pathogenic rs104894366 GRCh38 Chromosome 12, 25245284: 25245284
7 KRAS NM_004985.4(KRAS): c.15A> T (p.Lys5Asn) single nucleotide variant Pathogenic rs104894361 GRCh37 Chromosome 12, 25398304: 25398304
8 KRAS NM_004985.4(KRAS): c.15A> T (p.Lys5Asn) single nucleotide variant Pathogenic rs104894361 GRCh38 Chromosome 12, 25245370: 25245370
9 KRAS NM_004985.4(KRAS): c.468C> G (p.Phe156Leu) single nucleotide variant Pathogenic rs104894362 GRCh37 Chromosome 12, 25362828: 25362828
10 KRAS NM_004985.4(KRAS): c.468C> G (p.Phe156Leu) single nucleotide variant Pathogenic rs104894362 GRCh38 Chromosome 12, 25209894: 25209894
11 KRAS NM_033360.3(KRAS): c.211T> C (p.Tyr71His) single nucleotide variant Pathogenic rs387907205 GRCh37 Chromosome 12, 25380247: 25380247
12 KRAS NM_033360.3(KRAS): c.211T> C (p.Tyr71His) single nucleotide variant Pathogenic rs387907205 GRCh38 Chromosome 12, 25227313: 25227313
13 KRAS NM_004985.4(KRAS): c.439A> G (p.Lys147Glu) single nucleotide variant Pathogenic rs387907206 GRCh37 Chromosome 12, 25378559: 25378559
14 KRAS NM_004985.4(KRAS): c.439A> G (p.Lys147Glu) single nucleotide variant Pathogenic rs387907206 GRCh38 Chromosome 12, 25225625: 25225625
15 KRAS NM_004985.4(KRAS): c.65A> G (p.Gln22Arg) single nucleotide variant Pathogenic rs727503110 GRCh37 Chromosome 12, 25398254: 25398254
16 KRAS NM_004985.4(KRAS): c.65A> G (p.Gln22Arg) single nucleotide variant Pathogenic rs727503110 GRCh38 Chromosome 12, 25245320: 25245320

Expression for Cardiofaciocutaneous Syndrome 2

Search GEO for disease gene expression data for Cardiofaciocutaneous Syndrome 2.

Pathways for Cardiofaciocutaneous Syndrome 2

GO Terms for Cardiofaciocutaneous Syndrome 2

Sources for Cardiofaciocutaneous Syndrome 2

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....